These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24026238)

  • 1. Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products.
    Cheng F; Ruscher K; Fransson LÅ; Mani K
    Glycobiology; 2013 Dec; 23(12):1510-9. PubMed ID: 24026238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.
    Cheng F; Cappai R; Ciccotosto GD; Svensson G; Multhaup G; Fransson LÅ; Mani K
    J Biol Chem; 2011 Aug; 286(31):27559-72. PubMed ID: 21642435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid nuclear transit and impaired degradation of amyloid β and glypican-1-derived heparan sulfate in Tg2576 mouse fibroblasts.
    Cheng F; Fransson LÅ; Mani K
    Glycobiology; 2015 May; 25(5):548-56. PubMed ID: 25527428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of glypican-1 autodegradation by NO-deprivation correlates with nuclear accumulation of amyloid beta in normal fibroblasts.
    Cheng F; Fransson LÅ; Mani K
    Glycoconj J; 2015 Dec; 32(9):675-84. PubMed ID: 26318599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein (APP)/APP-like protein 2 (APLP2) expression is required to initiate endosome-nucleus-autophagosome trafficking of glypican-1-derived heparan sulfate.
    Cheng F; Cappai R; Lidfeldt J; Belting M; Fransson LÅ; Mani K
    J Biol Chem; 2014 Jul; 289(30):20871-8. PubMed ID: 24898256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive and vitamin C-induced, NO-catalyzed release of heparan sulfate from recycling glypican-1 in late endosomes.
    Mani K; Cheng F; Fransson LA
    Glycobiology; 2006 Dec; 16(12):1251-61. PubMed ID: 16971378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory cytokines induce accumulation of glypican-1-derived heparan sulfate and the C-terminal fragment of β-cleaved APP in autophagosomes of dividing neuronal cells.
    Cheng F; Fransson LÅ; Mani K
    Glycobiology; 2020 Jul; 30(8):539-549. PubMed ID: 32039447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of apolipoprotein E4-dependent or chemical-induced accumulation of APP degradation products by vitamin C-induced release of heparan sulfate from glypican-1.
    Cheng F; Fransson LÅ; Mani K
    Glycobiology; 2021 Aug; 31(7):800-811. PubMed ID: 33403386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolin is a nuclear target of heparan sulfate derived from glypican-1.
    Cheng F; Belting M; Fransson LÅ; Mani K
    Exp Cell Res; 2017 May; 354(1):31-39. PubMed ID: 28300561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyanobacterial neurotoxin β-N-methylamino-l-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells.
    Cheng F; Fransson LÅ; Mani K
    Exp Cell Res; 2019 Jun; 379(2):172-181. PubMed ID: 30953622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate degradation products can associate with oxidized proteins and proteasomes.
    Mani K; Cheng F; Fransson LA
    J Biol Chem; 2007 Jul; 282(30):21934-44. PubMed ID: 17540770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome b561, copper, β-cleaved amyloid precursor protein and niemann-pick C1 protein are involved in ascorbate-induced release and membrane penetration of heparan sulfate from endosomal S-nitrosylated glypican-1.
    Cheng F; Fransson LÅ; Mani K
    Exp Cell Res; 2017 Nov; 360(2):171-179. PubMed ID: 28893506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction.
    Cheng F; Bourseau-Guilmain E; Belting M; Fransson LÅ; Mani K
    Glycobiology; 2016 Jun; 26(6):623-34. PubMed ID: 26791445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-conserved, S-nitrosylated cysteines in glypican-1 react with N-unsubstituted glucosamines in heparan sulfate and catalyze deaminative cleavage.
    Cheng F; Svensson G; Fransson LÅ; Mani K
    Glycobiology; 2012 Nov; 22(11):1480-6. PubMed ID: 22801553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells.
    Cheng F; Fransson LÅ; Mani K
    Glycobiology; 2022 Mar; 32(4):333-342. PubMed ID: 34939110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
    O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
    Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.